A randomized controlled study testing the efficacy of immunotherapies to control plasma HIV RNA concentrations upon interruption of highly active antiretroviral therapy (HAART)
Phase of Trial: Phase II
Latest Information Update: 16 Dec 2016
At a glance
- Drugs HIV vaccine vCP1452 (Primary) ; Aldesleukin
- Indications HIV infections
- Focus Therapeutic Use
- 17 Oct 2005 New trial record.